European Pharmacovigilance Congress 2026
EnglishEnglishConference overview
Become sponsor of European Pharmacovigilance Congress 2026, click here
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences thanks to its top-tier scientific content.
The high value of this year`s program is assured by the contribution of the key opinion leaders, experts and scientists included in the Scientific Advisory Group (SAG).
In addition, we are delighted to announce the new scientific partnership with the renowned
Department of Pharmacological and Biomolecular Sciences of the Milan University (Università degli Studi di Milano) and the confirmation of collaboration with the Institute of Pharmacovigilance.
The EUPV Scientific Advisory Group has very clear that pharmacovigilance main pillars are:
• Safety Science – Regulatory compliance – Operational excellence
• Implementation of new technologies – Effective communication
All these aspects are reflected in the agenda of this year’s congress.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
EUPV congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
The 8th European Pharmacovigilance Congress: speaker abstracts 2024
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress 2026 will be a mixed event!
November 18-19 | Virtual (9.00 – 5.30 pm)
December 3 | Milan* (4.00 – 7.00 pm) + Aperitif Cocktail (7.00 – 9.00 pm)
December 4 | Milan* (9.15 – 5.30 pm)
* at NH Milan Congress Centre
APERITIF COCKTAIL December 3 (7.00 – 9.00 pm)
At the conference venue, PEC organizes a Welcome Aperitif Cocktail that will take place together with interesting workshops. Reserve your place to meet and network with your colleagues and experts!
The intense, scientific interaction between speakers and delegates is a further invaluable plus of the event:
– 26 Topics
– 24 round tables
– 7 virtual parallel sessions
– 2 LECTIO Magistralis
– 3 F2F parallel workshops
Why attend?
- Learn about the latest Pharmacovigilance trends and updates
- Share experiences and solutions at a leading European event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies Delegates and Speakers
Who should attend?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
FEATURED TOPICS 2026
• DEVELOPMENTAL SAFETY FROM FIRST IN HUMAN TO MARKETING AUTHORIZATION APPLICATION
• TRANSLATION SAFETY
• SAFETY OF GENE THERAPIES AND RARE DISEASES
• SYNTHETIC DATA IN PHARMACOVIGILANCE: OPPORTUNITIES, RISKS AND REGULATORY REALITY
• NON-EU PV REQUIREMENTS (Africa, Asia Americas)
• SAFETY IN ACCELERATED PATHWAYS parallel)
• SAFETY OF DRUGS USED IN HEPATIC RARE DISEASES
• IMPACT OF NEW REGULATIONS AND GUIDELINES ON PV OPERATIONS
• REGULATORY REQUIREMENTS FOR IMPLEMENTING AI IN PV
• MEDICAL DEVICES & COMBINATION PRODUCTS SAFETY
• PRACTICAL EXAMPLES OF APPLYING AI TO PV
• SAFETY INFORMATION FROM PATIENTS´PERSPECTIVE
• COSMETOVIGILANCE AND SAFETY OF NUTRACEUTICALS PRODUCTS
• EMA COMPUTERIZED SYSTEMS UPDATES
• ECOPHARMACOVIGILANCE
• PHARMACOEPIDEMIOLOGY AND REAL-WORLD EVIDENCE IN PHARMACOVIGILANCE: FROM SIGNAL TO DECISION
• RISK MANAGEMENT SYSTEMS
• HUMAN MACHINE INTERFACE IN PV
• EFFICIENCY AND EFFECTIVENESS IN A RAPIDLY CHANGING PV LANDSCAPE
• AUDIT & INSPECTIONS
Scientific Advisory Group 2026
Felix Arellano
Senior Vice President and the Global Head of Safety & Risk Management | Roche
Ayman Ayoub
Vice President Safety Evaluation and Risk Management | GSK
Mattia Calissano
VP, Medical | SSI Strategy
Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Head of Pharmacovigilance and QPPV
Manuela Casula
Associate Professor at Department of Pharmacological and Biomolecular Sciences | University of Milan
Mircea Ciuca
Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Giovanni Furlan
Head Medical Safety Operations | Sandoz Germany
Calin A. Lungu
DDCS S.A., CEO
Hrvoje Maček
VP Pharmacovigilance Services | Clingen
Valentina Mancini
Senior Director Pharmacovigilance, QPPV | Shionogi Europe
Jan Petracek
CEO | iVigee, Director | Institute of Pharmacovigilance
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech
Ivana Šutalo
Innovative Products, Business Unit Lead / EU QPPV / LCPPV Croatia | PrimeVigilance Ltd.
SPEAKERS 2025 – SPEAKERS 2026 IN PROGRESS
Marko Korenjak
President of the European Liver Patients’ Association, former PRAC member
Ana Sofia Martins
PRAC Member | INFARMED, I.P. – Portugal
Petar Mas
PRAC HALMED
Sophia Trantza
Senior Pharmacovigilance Expert former PRAC Member Greece
Antonella Caselli
Senior Clinical & Safety Assessor | Italian Medicines Agency (AIFA), Italy (Tbc)
Cristina Arizmendi Vélez
Chief of Cosmetovigilance and Safety of Cosmetic Products | AEMPS
Lembit Rägo
Secretary-General | Council for International
Organizations of Medical Sciences (CIOMS)
Pilar Rayón
PRAC AEMPS
Kendal Harrison
Head of Vigilance Development | MHRA
Lina Seibokiene
Senior expert at the Pharmacovigilance and Poison Information Unit, SMCA / PRAC alternate member.
Elena Giovani
Head of the GVP Inspection Office | AIFA (Tbc)
Ana Maria Velasco Calle
GCP/GVP Inspector from the Spanish Agency of Medicines and Medical Devices
Dirk Mentzer
Head of Pharmacovigilance | Paul-Ehrlich-Institut (PEI)
Elena Prokofyeva
Head of safety in clinical trials unit, DG Post, FAMHP
Fazil Afzal
Senior Medical Assessor at Medicines and Healthcare products Regulatory Agency (MHRA) (tbc)
John Borg
Director Post-Licensing | Malta Medicines Authority
Robert Ball
Deputy Director | Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research, FDA
François Haguinet
Associate Director for Safety and Quantitative Innovation | GSK – Belgium
Anita Blackburn
Labeling Lead | Fortrea
Taxiarchis Botsis
Associate Professor | Johns Hopkins University School of Medicine – USA
Giuseppe Curigliano
Professor of Medical Oncology | University of Milano and European Institute of Oncology, IRCCS
Vjera Bilusic Vundac
Executive Director, Medical Writing | Primevigilance Ltd.-Croatia
Barbara De Bernardi
EU & UK Pharmacovigilance Qualified Person, VP, Head of Global QPPV Office Worldwide Medical & Safety | Pfizer
Ahmed Diaa Eldin
CEO | Baupharma
Margherita D’Antuono
EU-UK QPPV | Piramal Critical Care
Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University; Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Tina Amini
Director TA MedTech & Combination Products Consulting Ltd
Panos Tsintis
Medical Director | PLM Med Ltd – UK
Hanae Bourji Chergui
Regulatory Affairs Senior Specialist | Becton and Dickinson
Marie-Laure Kurzinger
Associate VP, Head of Pharmacoepidemiology – General Medicines, Pharmacovigilance and Patient Safety | Sanofi
Rory Littlebury
Head of PV System Oversight and QPPV Office | GSK – UK
Rajat Mohindra
Principal Medical Director, Precision Safety, Product Development Safety | F. Hoffmann-La Roche Ltd – SWISS
Valeria Di Clemente
Director Pharmacovigilance EU Cluster and LATAM | Baxter
Natasa Mihajlovic
Managing Director | Nostra Pharma
Antoine Pariente
Professor of Clinical Pharmacology and Pharmacoepidemiology, Head of the Public Health Research Department | Univ. Bordeaux
Adrian Roth
Principal Scientific Director Precision Safety, Pharma Development | Roche – Swiss
Michael Glaser
Safety Innovation Technology Director | GSK – USA
Ilaria Grisoni
Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals
Mariangela Amoroso
Country Medical Lead | Sanofi Italy
Lisa Stagi
Patient Safety Country Cluster Lead | Roche
Nancy Dreyer
Chief Scientific Officer retired IQVIA and Professor | Univ of North Carolina, Chapel Hill – USA
Michael Von Forstner
Head of Safety Science| Sobi
Fabio De Gregorio
Vice President, Head of Safety | Shionogi Europe – UK
Klaudija Marijanovic Barac
Sr. Director, Head of Teva Periodic reports and risk management Centre | Teva
Antonella Fretta
Senior Director | Pfizer
Valentina Strammiello
Interim Executive Director | European Patients’ Forum
Alberto Gramaccioli
Director of Quality Management and Inspection | Pfizer
Sabine Fuerst-Recktenwald
Head Clinical Development Pediatric Center of Excellence | Novartis Pharma AG
Snehal Haribhau Gaykar
Associate Director, Global Risk Management | Sandoz
Trevor Mill
Senior Vice President | SSI Strategy
Maddalena Lino
Safety Risk Lead Director | Pfizer
Paola Kruger
Expert Patient | EUPATI (European Patient’s Academy for Therapeutic Innovation)
David Chonzi
Medical Director | PV Safety Solutions
Mercedina del Papa
EU QPPV, UK QPPV, Strategic Advisor | PrimeVigilance
Elena Alcaraz
EU QPPV, UK QPPV, Strategic Advisor | PrimeVigilance
Sara Vodanovic
Director, Regulatory Intelligence and Analytics | PrimeVigilance
Dimitris Zampatis
Director Product Patient Safety (DPPS) | Sandoz
Catherine Tchinou
Head Medical Safety Biopharma | Sandoz
Igor Copot
Executive Director of Safety Systems | Primevigilance
Gabrièle Piaton-Breda
Research & Innovation Director | PLG
MEDIA PARTNER/COLLABORATIONS/SPONSORS 2026 – in progress
Sage Publishing
Scientific Media Partner
Sage Publishing
Scientific Media Partner
Published by Sage Publishing, Therapeutic Advances in Drug Safety (Impact Factor: 3.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
E-mail: shasha.sharief@sagepub.co.uk
Twitter: @TADrugSafety
Visit our website »
Institute of Pharmacovigilance
Collaboration
Institute of Pharmacovigilance
Collaboration
Founded in 2015, the Institute of Pharmacovigilance (IPV) is a not-for-profit, non-governmental global organization with a clear goal – to elevate the pharmacovigilance industry by competency and seniority certification.
In 2020, IPV partnered with the International Society of Pharmacovigilance (ISoP) to develop the Global Pharmacovigilance Professional Certification (GPPC), creating a globally recognized standard for PV professionals. The certification works with competency standards including knowledge, skills and attitudes suitable for every role in pharmacovigilance.
Committed to continuous innovation, IPV regularly updates its programs to reflect the latest advancements, ensuring certified professionals have practical knowledge and skills they can apply in their jobs immediately.
Visit our website »
Università degli Studi di Milano – Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership
Università degli Studi di Milano – Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership
Il Dipartimento di Scienze Farmacologiche e Biomolecolari “Rodolfo Paoletti” (DiSFeB), nominato Dipartimento di Eccellenza 2023-2027, nasce il 27 aprile 2012 dall’aggregazione di settori scientifico disciplinari con comuni interessi di ricerca scientifica di alto profilo, e assicura un’equilibrata valorizzazione di tutti i settori scientifico-disciplinari che vi afferiscono. Il DiSFeB mira a consolidare il suo ruolo chiave nelle attività didattiche e di ricerca, e a rinnovare il suo portfolio di competenze tecnico-scientifiche a beneficio della società, contribuendo nel campo delle scienze biologiche applicate alla salute umana, alla prevenzione delle malattie e alla progettazione di farmaci e prodotti per la salute.
Visit our website »
Insuvia
Exhibitor
Insuvia
Exhibitor
Insuvia is designed to act as a pharmacovigilance unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities. In this context, we provide the regional EU and country-level expertise to solve all pharmacovigilance challenges that pharmaceutical companies encounter while commercializing their products.
Visit our website »
iVigee
Platinum Sponsor
iVigee
Platinum Sponsor
iVigee is a leading pharmacovigilance services and technology company focused on creating simple, powerful, and elegant drug safety solutions that span the entire drug safety life cycle.
We combine years of experience with the latest innovative AI technologies to create the ‘instant pharmacovigilance department’, deployable anywhere, on-demand.
Our teams support clients around the world with progressive pharmacovigilance and data management requirements from our strategic bases in Central Europe and the US East Coast.
iVigee: Simple. Powerful. Elegant.
Visit our website »
ProductLife Group
Exhibitor
ProductLife Group
Exhibitor
ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions.
Since 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, market access, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics.
With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.
Visit our website »
Become a sponsor
Don’t miss the chance to be a European Pharmacovigilance Congress 2026 sponsor!
Contact us to learn about our sponsorship packages, you will have the opportunity to:
• Deliver a talk in person or online
• Conduct a parallel session during the day in Milan
• Network and connect with your target customers
Check out our sponsorship opportunities here: Become EUPV Sponsor
Conference Venue
Step 1
On November 18-19 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on December 3-4! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
COCKTAIL DINNER December 3, 2026 (NH Milano Congress Centre, in Assago, Milan)
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
By plane
From Malpensa Airport:
-
- take the bus to the central station, then the subway towards Assago Milanofiori Forum
- take the express train from Malpensa to the Cadorna station, then the Green subway in the direction of Assago Milanofiori Forum.
From Linate Airport:
take the bus to San Babila station, then the subway towards Assago Milanofiori Forum.
By train
From Centrale or Cadorna train station, take green line subway to Assago Milanofiori Forum.
By tram
From Piazza del Duomo:
take the red subway line towards RHO FIERAMILANO and change at CADORNA. Take the green line towards ASSAGO MILANOFIORI FORUM and get off at the Assago Milanofiori Forum stop. Walk for about 7 minutes to reach the hotel.
All the past editions
Conference overview
Become sponsor of European Pharmacovigilance Congress 2026, click here
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated global pharmacovigilance conferences thanks to its top-tier scientific content.
The high value of this year`s program is assured by the contribution of the key opinion leaders, experts and scientists included in the Scientific Advisory Group (SAG).
In addition, we are delighted to announce the new scientific partnership with the renowned
Department of Pharmacological and Biomolecular Sciences of the Milan University (Università degli Studi di Milano) and the confirmation of collaboration with the Institute of Pharmacovigilance.
The EUPV Scientific Advisory Group has very clear that pharmacovigilance main pillars are:
• Safety Science – Regulatory compliance – Operational excellence
• Implementation of new technologies – Effective communication
All these aspects are reflected in the agenda of this year’s congress.
The EUPV congress gathers PV professionals at all career levels, including key decision makers (e.g. VPs, Executives and Directors) interested in the always evolving pharmacovigilance world and its new trends, since they are always looking for new ideas to implement more efficient and effective strategies and tools for their departments.
EUPV congress is the forum where all PV stakeholders from all over the world meet and exchange ideas.
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
The 7th European Pharmacovigilance Congress: speaker abstracts 2023
The 8th European Pharmacovigilance Congress: speaker abstracts 2024
Published by Sage Journals, visit their website here
Format del congresso
The European Pharmacovigilance Congress 2026 will be a mixed event!
November 18-19 | Virtual (9.00 – 5.30 pm)
December 3 | Milan* (4.00 – 7.00 pm) + Aperitif Cocktail (7.00 – 9.00 pm)
December 4 | Milan* (9.15 – 5.30 pm)
* at NH Milan Congress Centre
APERITIF COCKTAIL December 3 (7.00 – 9.00 pm)
At the conference venue, PEC organizes a Welcome Aperitif Cocktail that will take place together with interesting workshops. Reserve your place to meet and network with your colleagues and experts!
The intense, scientific interaction between speakers and delegates is a further invaluable plus of the event:
– 26 Topics
– 24 round tables
– 7 virtual parallel sessions
– 2 LECTIO Magistralis
– 3 F2F parallel workshops
Why attend?
- Learn about the latest Pharmacovigilance trends and updates
- Share experiences and solutions at a leading European event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies Delegates and Speakers
Who should attend?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
FEATURED TOPICS 2026
• DEVELOPMENTAL SAFETY FROM FIRST IN HUMAN TO MARKETING AUTHORIZATION APPLICATION
• TRANSLATION SAFETY
• SAFETY OF GENE THERAPIES AND RARE DISEASES
• SYNTHETIC DATA IN PHARMACOVIGILANCE: OPPORTUNITIES, RISKS AND REGULATORY REALITY
• NON-EU PV REQUIREMENTS (Africa, Asia Americas)
• SAFETY IN ACCELERATED PATHWAYS parallel)
• SAFETY OF DRUGS USED IN HEPATIC RARE DISEASES
• IMPACT OF NEW REGULATIONS AND GUIDELINES ON PV OPERATIONS
• REGULATORY REQUIREMENTS FOR IMPLEMENTING AI IN PV
• MEDICAL DEVICES & COMBINATION PRODUCTS SAFETY
• PRACTICAL EXAMPLES OF APPLYING AI TO PV
• SAFETY INFORMATION FROM PATIENTS´PERSPECTIVE
• COSMETOVIGILANCE AND SAFETY OF NUTRACEUTICALS PRODUCTS
• EMA COMPUTERIZED SYSTEMS UPDATES
• ECOPHARMACOVIGILANCE
• PHARMACOEPIDEMIOLOGY AND REAL-WORLD EVIDENCE IN PHARMACOVIGILANCE: FROM SIGNAL TO DECISION
• RISK MANAGEMENT SYSTEMS
• HUMAN MACHINE INTERFACE IN PV
• EFFICIENCY AND EFFECTIVENESS IN A RAPIDLY CHANGING PV LANDSCAPE
• AUDIT & INSPECTIONS
Scientific Advisory Group 2026
Felix Arellano
Senior Vice President and the Global Head of Safety & Risk Management | Roche
Ayman Ayoub
Vice President Safety Evaluation and Risk Management | GSK
Mattia Calissano
VP, Medical | SSI Strategy
Gian Nicola Castiglione
Pharmacovigilance Senior Consultant, Member and Secretary of SIMeF, ETS Board, Master of Labor. Head of Pharmacovigilance and QPPV
Manuela Casula
Associate Professor at Department of Pharmacological and Biomolecular Sciences | University of Milan
Mircea Ciuca
Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Giovanni Furlan
Head Medical Safety Operations | Sandoz Germany
Calin A. Lungu
DDCS S.A., CEO
Hrvoje Maček
VP Pharmacovigilance Services | Clingen
Valentina Mancini
Senior Director Pharmacovigilance, QPPV | Shionogi Europe
Jan Petracek
CEO | iVigee, Director | Institute of Pharmacovigilance
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV| ADIENNE Pharma & Biotech
Ivana Šutalo
Innovative Products, Business Unit Lead / EU QPPV / LCPPV Croatia | PrimeVigilance Ltd.
SPEAKERS 2025 - SPEAKERS 2026 IN PROGRESS
Marko Korenjak
President of the European Liver Patients’ Association, former PRAC member
Ana Sofia Martins
PRAC Member | INFARMED, I.P. – Portugal
Petar Mas
PRAC HALMED
Sophia Trantza
Senior Pharmacovigilance Expert former PRAC Member Greece
Antonella Caselli
Senior Clinical & Safety Assessor | Italian Medicines Agency (AIFA), Italy (Tbc)
Cristina Arizmendi Vélez
Chief of Cosmetovigilance and Safety of Cosmetic Products | AEMPS
Lembit Rägo
Secretary-General | Council for International
Organizations of Medical Sciences (CIOMS)
Pilar Rayón
PRAC AEMPS
Kendal Harrison
Head of Vigilance Development | MHRA
Lina Seibokiene
Senior expert at the Pharmacovigilance and Poison Information Unit, SMCA / PRAC alternate member.
Elena Giovani
Head of the GVP Inspection Office | AIFA (Tbc)
Ana Maria Velasco Calle
GCP/GVP Inspector from the Spanish Agency of Medicines and Medical Devices
Dirk Mentzer
Head of Pharmacovigilance | Paul-Ehrlich-Institut (PEI)
Elena Prokofyeva
Head of safety in clinical trials unit, DG Post, FAMHP
Fazil Afzal
Senior Medical Assessor at Medicines and Healthcare products Regulatory Agency (MHRA) (tbc)
John Borg
Director Post-Licensing | Malta Medicines Authority
Robert Ball
Deputy Director | Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research, FDA
François Haguinet
Associate Director for Safety and Quantitative Innovation | GSK – Belgium
Anita Blackburn
Labeling Lead | Fortrea
Taxiarchis Botsis
Associate Professor | Johns Hopkins University School of Medicine – USA
Giuseppe Curigliano
Professor of Medical Oncology | University of Milano and European Institute of Oncology, IRCCS
Vjera Bilusic Vundac
Executive Director, Medical Writing | Primevigilance Ltd.-Croatia
Barbara De Bernardi
EU & UK Pharmacovigilance Qualified Person, VP, Head of Global QPPV Office Worldwide Medical & Safety | Pfizer
Ahmed Diaa Eldin
CEO | Baupharma
Margherita D'Antuono
EU-UK QPPV | Piramal Critical Care
Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University; Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Tina Amini
Director TA MedTech & Combination Products Consulting Ltd
Panos Tsintis
Medical Director | PLM Med Ltd – UK
Hanae Bourji Chergui
Regulatory Affairs Senior Specialist | Becton and Dickinson
Marie-Laure Kurzinger
Associate VP, Head of Pharmacoepidemiology – General Medicines, Pharmacovigilance and Patient Safety | Sanofi
Rory Littlebury
Head of PV System Oversight and QPPV Office | GSK – UK
Rajat Mohindra
Principal Medical Director, Precision Safety, Product Development Safety | F. Hoffmann-La Roche Ltd – SWISS
Valeria Di Clemente
Director Pharmacovigilance EU Cluster and LATAM | Baxter
Natasa Mihajlovic
Managing Director | Nostra Pharma
Antoine Pariente
Professor of Clinical Pharmacology and Pharmacoepidemiology, Head of the Public Health Research Department | Univ. Bordeaux
Adrian Roth
Principal Scientific Director Precision Safety, Pharma Development | Roche – Swiss
Michael Glaser
Safety Innovation Technology Director | GSK – USA
Ilaria Grisoni
Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals
Mariangela Amoroso
Country Medical Lead | Sanofi Italy
Lisa Stagi
Patient Safety Country Cluster Lead | Roche
Nancy Dreyer
Chief Scientific Officer retired IQVIA and Professor | Univ of North Carolina, Chapel Hill – USA
Michael Von Forstner
Head of Safety Science| Sobi
Fabio De Gregorio
Vice President, Head of Safety | Shionogi Europe – UK
Klaudija Marijanovic Barac
Sr. Director, Head of Teva Periodic reports and risk management Centre | Teva
Antonella Fretta
Senior Director | Pfizer
Valentina Strammiello
Interim Executive Director | European Patients’ Forum
Alberto Gramaccioli
Director of Quality Management and Inspection | Pfizer
Sabine Fuerst-Recktenwald
Head Clinical Development Pediatric Center of Excellence | Novartis Pharma AG
Snehal Haribhau Gaykar
Associate Director, Global Risk Management | Sandoz
Trevor Mill
Senior Vice President | SSI Strategy
Maddalena Lino
Safety Risk Lead Director | Pfizer
Paola Kruger
Expert Patient | EUPATI (European Patient’s Academy for Therapeutic Innovation)
David Chonzi
Medical Director | PV Safety Solutions
Mercedina del Papa
EU QPPV, UK QPPV, Strategic Advisor | PrimeVigilance
Elena Alcaraz
EU QPPV, UK QPPV, Strategic Advisor | PrimeVigilance
Sara Vodanovic
Director, Regulatory Intelligence and Analytics | PrimeVigilance
Dimitris Zampatis
Director Product Patient Safety (DPPS) | Sandoz
Catherine Tchinou
Head Medical Safety Biopharma | Sandoz
Igor Copot
Executive Director of Safety Systems | Primevigilance
Gabrièle Piaton-Breda
Research & Innovation Director | PLG
MEDIA PARTNER/COLLABORATIONS/SPONSORS 2026 - in progress
Sage Publishing
Scientific Media Partner
Sage Publishing
Scientific Media Partner
Published by Sage Publishing, Therapeutic Advances in Drug Safety (Impact Factor: 3.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
E-mail: shasha.sharief@sagepub.co.uk
Twitter: @TADrugSafety
Visit our website »
Institute of Pharmacovigilance
Collaboration
Institute of Pharmacovigilance
Collaboration
Founded in 2015, the Institute of Pharmacovigilance (IPV) is a not-for-profit, non-governmental global organization with a clear goal – to elevate the pharmacovigilance industry by competency and seniority certification.
In 2020, IPV partnered with the International Society of Pharmacovigilance (ISoP) to develop the Global Pharmacovigilance Professional Certification (GPPC), creating a globally recognized standard for PV professionals. The certification works with competency standards including knowledge, skills and attitudes suitable for every role in pharmacovigilance.
Committed to continuous innovation, IPV regularly updates its programs to reflect the latest advancements, ensuring certified professionals have practical knowledge and skills they can apply in their jobs immediately.
Visit our website »
Università degli Studi di Milano - Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership
Università degli Studi di Milano - Dipartimento di Scienze Farmacologiche e Biomolecolari
Scientific Partnership
Il Dipartimento di Scienze Farmacologiche e Biomolecolari “Rodolfo Paoletti” (DiSFeB), nominato Dipartimento di Eccellenza 2023-2027, nasce il 27 aprile 2012 dall’aggregazione di settori scientifico disciplinari con comuni interessi di ricerca scientifica di alto profilo, e assicura un’equilibrata valorizzazione di tutti i settori scientifico-disciplinari che vi afferiscono. Il DiSFeB mira a consolidare il suo ruolo chiave nelle attività didattiche e di ricerca, e a rinnovare il suo portfolio di competenze tecnico-scientifiche a beneficio della società, contribuendo nel campo delle scienze biologiche applicate alla salute umana, alla prevenzione delle malattie e alla progettazione di farmaci e prodotti per la salute.
Visit our website »
Insuvia
Exhibitor
Insuvia
Exhibitor
Insuvia is designed to act as a pharmacovigilance unit for pharmaceutical companies in those countries and regions, where they have no internal structures or decide to focus their resources on commercial activities. In this context, we provide the regional EU and country-level expertise to solve all pharmacovigilance challenges that pharmaceutical companies encounter while commercializing their products.
Visit our website »
iVigee
Platinum Sponsor
iVigee
Platinum Sponsor
iVigee is a leading pharmacovigilance services and technology company focused on creating simple, powerful, and elegant drug safety solutions that span the entire drug safety life cycle.
We combine years of experience with the latest innovative AI technologies to create the ‘instant pharmacovigilance department’, deployable anywhere, on-demand.
Our teams support clients around the world with progressive pharmacovigilance and data management requirements from our strategic bases in Central Europe and the US East Coast.
iVigee: Simple. Powerful. Elegant.
Visit our website »
ProductLife Group
Exhibitor
ProductLife Group
Exhibitor
ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions.
Since 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, market access, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics.
With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.
Visit our website »
Become a sponsor
Don’t miss the chance to be a European Pharmacovigilance Congress 2026 sponsor!
Contact us to learn about our sponsorship packages, you will have the opportunity to:
• Deliver a talk in person or online
• Conduct a parallel session during the day in Milan
• Network and connect with your target customers
Check out our sponsorship opportunities here: Become EUPV Sponsor
Conference Venue
Step 1
On November 18-19 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on December 3-4! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.
COCKTAIL DINNER December 3, 2026 (NH Milano Congress Centre, in Assago, Milan)
PLEASE NOTE:
Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
By plane
From Malpensa Airport:
-
- take the bus to the central station, then the subway towards Assago Milanofiori Forum
- take the express train from Malpensa to the Cadorna station, then the Green subway in the direction of Assago Milanofiori Forum.
From Linate Airport:
take the bus to San Babila station, then the subway towards Assago Milanofiori Forum.
By train
From Centrale or Cadorna train station, take green line subway to Assago Milanofiori Forum.
By tram
From Piazza del Duomo:
take the red subway line towards RHO FIERAMILANO and change at CADORNA. Take the green line towards ASSAGO MILANOFIORI FORUM and get off at the Assago Milanofiori Forum stop. Walk for about 7 minutes to reach the hotel.
All the past editions
Sign up for the conference
Face to Face (3-4/12/2026) | 450€ |
Virtual (18-19/11/2026) | 750€ |
Virtual + Face to Face (18-19/11/2026 and 3-4/12/2026) | 880€ |
PLEASE NOTE: Ticket options labeled ‘+ Visa’ are intended for participants who need to request a visa invitation letter in order to attend the event. If you need more information contact info@pharmaeducationcenter.it
* Hospitals, Universities and freelancers get a 40% discount on published prices (discounts cannot be combined).